Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xycrobe Therapeutics

Xycrobe Therapeutics
2014 FOUNDED
M&A STATUS
1-10 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of biotechnological services. The company uses data generated from the human microbiome to develop therapies to address the needs of patients with inflammatory skin disease.

Website
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States

Xycrobe Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Xycrobe Therapeutics‘s full profile, request access.

Request full access to PitchBook

Xycrobe Therapeutics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Xycrobe Therapeutics‘s full profile, request access.

Request full access to PitchBook

Xycrobe Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Thomas Hitchcock Ph.D Founder, Chief Executive Officer and Board Member